Although the prognostic significance for BRAF mutants remains unclear since controversial results were reported [38–41], the occurrence of BRAF mutations seems to have no impact on the disease-free interval from diagnosis of first-ever melanoma to first distant metastasis, but may worsen the overall survival after disease progression [42•]. This evidence concerns the gene BRAF and melanoma.